...
首页> 外文期刊>Molecular medicine reports >Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1
【24h】

Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1

机译:隐性视神经萎缩,感觉运动神经病和白内障与OPA1中新的复合杂合突变相关

获取原文
获取原文并翻译 | 示例

摘要

Mutations in the optic atrophy 1 gene (OPA1) are associated with autosomal dominant optic atrophy and 20% of patients demonstrate extra-ocular manifestations. In addition to these autosomal dominant cases, only a few syndromic cases have been reported thus far with compound heterozygous OPA1 mutations, suggestive of either recessive or semi-dominant patterns of inheritance. The majority of these patients were diagnosed with Behr syndrome, characterized by optic atrophy, ataxia and peripheral neuropathy. The present study describes a 10-year-old boy with Behr syndrome presenting with early-onset severe optic atrophy, sensorimotor neuropathy, ataxia and congenital cataracts. He had optic atrophy and was declared legally blind at six years old. Electrophysiological, radiological, and histopathological findings were compatible with axonal sensorimotor polyneuropathy. At birth, he presented with a congenital cataract, which has not been previously described in patients with OPA1 mutations. Whole exome sequencing indicated a pair of novel compound heterozygous mutations: p.L620fs*13 (c.1857-1858delinsT) and p.R905Q (c.G2714A). Neither mutation was observed in controls (n=300), and thus, they were predicted to be pathogenic by multiple in silico analyses. The mutation sites were highly conserved throughout different vertebrate species. The patients parents did not have any ophthalmic or neurologic symptoms and the results of electro-physiological studies were normal, suggestive of an autosomal recessive pattern of inheritance. The present study identified novel compound heterozygous OPA1 mutations in a patient with recessive optic atrophy, sensorimotor neuropathy and congenital cataracts, indicating an expansion of the clinical spectrum of pathologies associated with OPA1 mutations. Thus, OPA1 gene screening is advisable in the workup of patients with recessive optic atrophy, particularly with Behr syndrome and cataracts.
机译:视神经萎缩1基因(OPA1)中的突变与常染色体显性视神经萎缩相关,并且20%的患者表现出眼外表现。除这些常染色体显性病例外,迄今仅报道了少数具有复合杂合OPA1突变的综合征病例,提示隐性或半显性遗传模式。这些患者中大多数被诊断出患有视神经萎缩,共济失调和周围神经病。本研究描述了一个患有Behr综合征的10岁男孩,患有早期发作的严重视神经萎缩,感觉运动神经病,共济失调和先天性白内障。他患有视神经萎缩,六岁时被宣布为合法盲人。电生理,放射学和组织病理学发现与轴突感觉运动性多神经病相容。他出生时表现为先天性白内障,以前在OPA1突变患者中未曾描述过。整个外显子组测序表明一对新的化合物杂合突变:p.L620fs * 13(c.1857-1858delinsT)和p.R905Q(c.G2714A)。在对照中(n = 300)未观察到任何突变,因此,通过多次计算机分析可预测它们是致病的。突变位点在整个不同脊椎动物物种中高度保守。患者父母没有任何眼科或神经系统症状,电生理研究结果正常,提示遗传是常染色体隐性遗传。本研究在患有隐性视神经萎缩,感觉运动神经病和先天性白内障的患者中发现了新的复合杂合OPA1突变,这表明与OPA1突变相关的临床病理学范围有所扩大。因此,OPA1基因筛查在隐性视神经萎缩,特别是伴有Behr综合征和白内障的患者的检查中是可取的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号